Login

Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights from J.C. Flowers on Financial Institutions and Investment Strategy | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
BWRX300: Promising SMR by GE Hitachi | GE Hitachi - Vice President of Small Modular Reactors
00:10:00
Oil Rally Insights: Short-Term Gains vs. Long-Term Bear Market
00:10:00
MolyWorks Improves Air-Worthy Aerospace Part Production Capabilities | Jeffrey A Graves, CEO, 3D Systems CorpDDD*:MEX
00:10:00
An interview with Vinod Kaul, General Manager - South Asia of Gilat Satellite Networks.
00:10:00
Commercial and Financial Milestones in the First Quarter | Steven van Rijswijk , CEO, ING Group .
00:10:00
The short film highlighting GWEC and its members includes PNE AG's contributions, featuring an interview with CEO Markus Lesser, starting at a pivotal moment.
00:10:00
investing in Miami with his new incubator Pareto|Jon Oringer,Co-Founder,Shutterstock
00:10:00
Power of Disrupting Financial Systems|Kwame Anku,Chairman & CEO,Black Star Fund
00:10:00
Advancing Precision Therapies for Kidney Diseases: Chinook's Pipeline and Clinical Progress Overview | Eric Dobmeier, CEO, Chinook Therapeutics Inc.
00:10:00
Navigating the Energy Transition: Insights on Inputs, Outputs, and Metal-Mining Implications
00:10:00
From Big Ideas to Big Impact: Chris Marlett on MDB Capital's Evolution and IPO Strategy

© 2017 - Neuhu+